EN   EN 
 
 
 EUROPEAN  
COMMISSION   
Brussels, XXX   
PLAN/243/2023 
(POOL/E4/2023/243/243 -EN.docx)  
[…](2023) XXX  draft  
 
COMMISSION IMPLEMENTING DECISION (EU) …/…  
of XXX  
repealing Implementing Decision (EU) 2022/1486 postponing the expiry date of the 
approval of acrolein for use in biocidal products of product -type 12  
(Text with EEA relevance)    
EN 1  EN COMMISSION IMPLEMENTING DECISION (EU) …/…  
of XXX  
repealing Implementing Decision (EU) 2022/1486 postponing the expiry date of the 
approval of acrolein for use in biocidal products of product -type 12  
(Text with EEA relevance)  
THE EUROPEAN COMMISSION,  
Having regard to the Treaty on the Functioning of the European Union , 
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the 
Council of 22 May 2012 concerning the making available on the market and use of biocidal 
products1, and in particular Article 14( 5) thereof,  
After consulting the Standing Co mmittee on Biocidal Products , 
Whereas:  
(1) Acrolein  was included in Annex I to Directive 98/8/EC of the European Parliament 
and of the Council2 as an active substance for use in bio cidal products of product -type 
12. Pursuant to Article 86 of Regulation (EU) No  528/2012 , it was therefore 
considered approved until 31 August 2020 under that Regulation subject to the 
requirements  set out in Annex I to Directive 98/8/EC.  
(2) On 28 February  2019, an application was submitted in accordance with Article 13(1) 
of Regulation  (EU) No 528/2012 for the renewal of the approval  of acrolein for use in 
biocidal products of product -type 12  (‘the application’ ) as the approval of acrolein for 
use in biocidal products of product -type 12 was supposed to expire  on 31 August 
2020.  
(3) Commissi on Implementing Decision (EU) 20 20/10373 postponed  the expiry date of 
the approval of acrolein  for use in biocidal products of product -type 12 to 28 February  
2023 in order to allow sufficient time for the examination of the application . That 
expiry was again postponed by Commission Implementing Decision (EU) 202 2/14864 
to 28 February 2025.  
(4) However, o n 6 October  2022, the evaluating competent authority of Czechia informed  
the Agency and  the Commission that the applicant had withdrawn its application for 
the renewal of approval of acrolein for use in biocidal products of product -type 12 . 
Consequentl y, as it has not been established that acrolein still meets the conditions laid 
down in Article 4(1) of Regulation (EU) No 528/2012 , Commission Implementing 
                                                 
1 OJ L 167, 27.6.2012, p. 1.   
2 Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the 
placing of biocidal products on the market (OJ L 123, 24.4.1998,  p.1). 
3 Commission Implementing Decision (EU) 20 20/1037 of 15 July 2020 postponing the expiry date of 
approval of acrolein  for use in biocidal products of product -type 12 (OJ L 227, 16.7.2020, p. 72). 
4 Commission Implementing Decision (EU) 2022/1486 of 7 September 2022 postponing the expiry date 
of the approval of  acrolein for use in biocidal products of product -type 12 in accordance with 
Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 233, 8.9.2022, p. 
83).  
EN 2  EN Decision  (EU) C(2023)  16005 [Publication office please add here the number of this 
Decision  once it is associated, along the whole Decision ] did not renew the approval 
of acrolein for use in biocidal products of product -type 12 . Therefore, it is appropriate 
to repeal Commission Implementing Decision (EU) 2022/1486  postponing the expiry 
date of the approval of acrolein , 
HAS ADOPTED THIS DECISION:  
Article 1  
Implementing Decision (EU) 2022/1486  is repealed.  
Article 2 
This Decision shall enter into force on the twentieth day following that of its publication in 
the Official Journal of the European Union . 
Done at Brussels,  
 For the Commission  
 The President  
 Ursula V ON DER LEYEN   
 
                                                 
5 Commission Implementing Decision  (EU) C(2023 ) 1600  of XXX  not renewing the approval of acrolein 
for use in biocidal products of product -type 12 in accordance with Regulation (EU) No 528/2012 of the 
European Parliament and of the Council ( OJ L …, …, p. …).